Examples of 'cinacalcet' in a sentence
Meaning of "cinacalcet"
cinacalcet (adjective) - a term related to a medication that is used to treat problems related to parathyroid gland in patients with kidney failure. It helps in reducing levels of parathyroid hormone in the body
Show more definitions
- A drug C₂₂H₂₂F₃N·HCl (trademark Sensipar) that is administered orally to treat hyperparathyroidism in patients with chronic kidney failure undergoing dialysis and to treat certain types of hypercalcemia (as that associated with parathyroid carcinoma). It increases the sensitivity of receptor cells of the parathyroid gland to extracellular calcium causing a decrease in parathyroid hormone secretion.
How to use "cinacalcet" in a sentence
Basic
Advanced
cinacalcet
Cinacalcet has not been tested in pregnant women.
Mimpara contains the active substance cinacalcet.
Dose adjustment of cinacalcet may be required.
Cinacalcet did not show any genotoxic or carcinogenic potential.
In one option the agonist is cinacalcet hydrochloride.
Clearance of cinacalcet may be lower in women than in men.
Parareg is a medicine containing the active substance cinacalcet.
Overdose of cinacalcet may lead to hypocalcaemia.
Mimpara is a medicine containing the active substance cinacalcet.
The pharmacokinetics of cinacalcet does not change over time.
Cinacalcet is an allosteric activator of the calcium sensor receptor.
It is not known whether cinacalcet is excreted in human milk.
Cinacalcet has been shown to cross the placental barrier in rabbits.
Patients receiving cinacalcet should not be given etelcalcetide.
Cinacalcet can alternatively be prepared using peptide coupling methods.
See also
A process for the preparation of cinacalcet and intermediates thereof.
Dizziness and seizures have been reported by patients taking cinacalcet.
Protein binding of cinacalcet is not affected by impaired hepatic function.
There are no clinical data relating to the effect of cinacalcet on fertility.
Effect of cinacalcet on other medications.
Reduce or withhold dose of cinacalcet.
Effect of cinacalcet on other medicines.
The active substance is cinacalcet.
Process for preparing cinacalcet and pharmaceutically acceptable salts thereof.
Mimpara is a medicine that contains the active substance cinacalcet.
Recovering the cinacalcet salt.
There are no clinically relevant differences due to age in the pharmacokinetics of cinacalcet.
With said process it is possible to obtain cinacalcet hydrochloride in purified form.
Mild hepatic impairment did not notably affect the pharmacokinetics of cinacalcet.
Tell your doctor if you are taking cinacalcet or have recently taken cinacalcet.
Rapid dissolution formulation of cinacalcet.
The cinacalcet hydrochloride can thus be obtained in crystalline and purified form.
Immediate release formulations of cinacalcet.
Cinacalcet can be prepared by coupling of an aryl halide with an appropriate corresponding compound.
Treatment should be reinitiated using the next lowest dose of cinacalcet.
Converting the cinacalcet into a pharmaceutically acceptable acid addition salt of cinacalcet.
There are no clinical data from the use of cinacalcet in pregnant women.
Compositions of cinacalcet hydrochloride prepared via any of the disclosed methods are disclosed.
Drug combinations for use in the invention comprise cinacalcet and tadalafil.
Cinacalcet is excreted in the milk of lactating rats with a high milk to plasma ratio.
The compositions can include the cinacalcet hydrochloride and a pharmaceutically acceptable carrier.
Cinacalcet is also indicated for the treatment of hypercalcemia in patients with parathyroid carcinoma.
Hyperparathyroidism will potentially be better managed once more patients are prescribed paricalcitol and cinacalcet.
The safety and efficacy of cinacalcet in the paediatric population have not been established.
Hypersensitivity reactions including angioedema and urticaria have been identified during postmarketing use of cinacalcet.
The cinacalcet HCl used in the composition is typically present in the form of particles.
The invention also relates to any pharmaceutical compositions per se comprising cinacalcet and tadalafil.
Cinacalcet Mylan is not indicated for use in paediatric patients.
Clinical data on the use of Cinacalcet during pregnancy are absent.
Cinacalcet Mylan should be taken with or shortly after food.
